当前位置:
X-MOL 学术
›
Cancer Discov.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Trastuzumab Deruxtecan Is Safe and Active in HER2-Expressing Tumors
Cancer Discovery ( IF 28.2 ) Pub Date : 2017-12-01 , DOI: 10.1158/2159-8290.cd-rw2017-202 American Association for Cancer Research
中文翻译:
曲妥珠单抗Deruxtecan在表达HER2的肿瘤中安全且活跃
更新日期:2017-12-05
Cancer Discovery ( IF 28.2 ) Pub Date : 2017-12-01 , DOI: 10.1158/2159-8290.cd-rw2017-202 American Association for Cancer Research
Trastuzumab deruxtecan achieved responses in patients with breast, gastric, and gastroesophageal tumors.
中文翻译:
曲妥珠单抗Deruxtecan在表达HER2的肿瘤中安全且活跃
曲妥珠单抗deruxtecan在患有乳腺,胃和胃食管肿瘤的患者中获得了缓解。